Orthopedic imaging relies on X-ray, MRI and CT to diagnose disorders and injuries affecting the bones, muscles, ligaments, tendons, cartilage, and spine. Orthopedists also use these test results to create an effective treatment plan.
Genicular artery embolization targets synovial blood vessel abnormalities believed to cause painful inflammation that contributes to the severe discomfort most patients experience with OA.
The goal of the study is to obtain quantitative data on how daily training and competing affect players’ musculoskeletal health. The information will be used to inform training, rest and recovery periods.
Although gadolinium-based contrast agents are largely considered safe and are routinely used for MRI exams, experts suggest that providers should still utilize GBCAs sparingly for musculoskeletal studies.
Although rare, SIRVA made its way into headlines following the widespread rollout of COVID vaccines. This prompted a renewed push among the medical community to better define the side effect.
Such scans offer significant reductions in radiation exposure, but there is concern that lower dosage might sacrifice image quality, causing readers to miss important findings.
Experts recently compared the use of a 0.55T low-field MRI system to a 1.5T system to determine whether the results rendered were within an acceptable diagnostic range.
A new paper in the European Journal of Radiology offers an updated overview of common MRI findings in patients who develop foot drop following total hip arthroplasty.
Once the go-to exam for gaining intra-articular details of major joints, MR arthrography appears to be wavering in popularity, decreasing 'drastically' at some institutions.
These errors are frequently due to a breakdown in communication between radiologists, technologists and referring providers, either before or during exams, according to a new analysis of more nearly 63,000 musculoskeletal MRI exams.
GE HealthCare's flurpiridaz, the PET radiotracer that recently received FDA approval, offers several key benefits over SPECT. Jamshid Maddahi, MD, discussed the details in an exclusive interview.
Ultrafast MCE could go on to become a go-to treatment option for obstructive coronary artery disease, according to the authors of a new first-in-human clinical study.